Tag Archives: Antibody

FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)

TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the U.S. Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. “We are… Read More »

COVID-19 Daily: More Will Die, First Antibody Test Authorized

What your doctor is reading on Medscape.com: APRIL 04, 2020 — Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today:  ID Experts: More Will Die Than Predicted  Anticipate a higher death rate from COVID-19 than originally predicted. That’s the message from leaders of the Infectious Diseases Society… Read More »